View Cart (0 items)

Pharmaceutical

FDA warns consumers to avoid fraudulent Ebola treatment products

No Comments
The agency said that it had seen and received consumer complaints about various products being offered online that are claimed to either prevent the Ebola virus or treat the infection.
Read More

Sanofi, MannKind agree on $925 million deal for inhaled insulin therapy

No Comments
Under the exclusive agreement with MannKind Corporation the two companies will collaborate on development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes.
Read More

Alvogen acquires South Korea's Dream Pharma

No Comments
Pharmaceutical company Alvogen has agreed to purchase Dream Pharma, based in South Korea, for $187 million in cash.
Read More

US pharmaceutical packaging products market valued at $22.1 billion

No Comments
U.S. demand for pharmaceutical packaging products is expected to increase slightly in the next few years as drug makers upgrade the barrier, security and functional properties of their packaging systems.
Read More

FDA reveals details on generic drugs watchdog reorganization

No Comments
The U.S. Food and Drug Administration (FDA) has announced details of its long-awaited reorganization of the Office of Generic Drugs (OGD).
Read More

Mylan Buys Abbott's Non-U.S. Generic Drugs Portfolio

No Comments
The deal will cost an estimated $5.3 billion and involve more than 100 products in several key areas.
Read More

Salix Pharmaceuticals to merge with Cosmo subsidiary

No Comments
U.S.-based Salix Pharmaceuticals Ltd. has announced plans to merge with a unit of Italian company Cosmo Pharmaceuticals, Cosmo Technologies Ltd.
Read More

Omnicare to pay $124 million to settle fraud allegations

No Comments
Cincinnati-based Omnicare Inc. is to pay more than $124 million in a settlement with the U.S. Department of Justice for allegedly offering financial incentives to healthcare facilities.
Read More

US regulator to tighten scrutiny on potential drug delay deals

No Comments
The U.S. Federal Trade Commission has announced plans to increase probes into pharmaceutical deals that potentially harm competition by delaying the launch of generic drugs on the market.
Read More

Merck to take over hepatitis C drug maker

No Comments
American pharmaceutical giant Merck & Co. is planning to buy Idenix Pharmaceuticals Inc., a Massachusetts-based company specializing in developing treatment for hepatitis C.
Read More